Asset Details
Do you wish to reserve the book?
KIN17 facilitates the initiation and progression of renal tumor progression through the PI3K-AKT-mTOR pathway
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
KIN17 facilitates the initiation and progression of renal tumor progression through the PI3K-AKT-mTOR pathway
Do you wish to request the book?
KIN17 facilitates the initiation and progression of renal tumor progression through the PI3K-AKT-mTOR pathway
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
KIN17 facilitates the initiation and progression of renal tumor progression through the PI3K-AKT-mTOR pathway
2026
Overview
KIN17, well known as a DNA and RNA binding protein, is highly involved in the regulation of tumorigenesis of diverse human cancers, but its function in the cancer progression and metastasis of Renal Cell Carcinoma (RCC) remains unclear. The aims of this study were to identify the role of KIN17 in RCC. We performed the study with the PI3K/mTOR inhibitor PF-04691502 in vivo and vitro, detected the tumor invasion and migration dysfunction by using Bioinformatics Analysis, IHC, Scratch Wound Healing Assay, Cell Viability Assay, Colony Formation Assays, EdU-647 Labeling, Cell Cycle and Apoptosis Detection by flow cytometer, Western Blotting, Animal Experiment. These findings suggest that the ability of KIN17 is to promote RCC cell proliferation, cycle progression, reduce cell apoptosis, increase cell clone formation, invasion, and increase cell migration and so on. As expected, PI3K/mTOR pathway inhibitor can reverse the ability of KIN17 in vivo and vitro. Meanwhile, PI3K/mTOR pathway inhibitor can reverse the activation of the PI3K/AKT/mTOR signaling pathway. Overall, our findings provide preliminary data which suggests KIN17 could be a promising migration and invasion prognostic biomarker, as well as a potential therapeutic target in RCC.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
1-Phosphatidylinositol 3-kinase
/ Animals
/ Carcinoma, Renal Cell - genetics
/ Carcinoma, Renal Cell - metabolism
/ Carcinoma, Renal Cell - pathology
/ Humanities and Social Sciences
/ Humans
/ Kidney Neoplasms - metabolism
/ Kidney Neoplasms - pathology
/ KIN17
/ Kinases
/ Mice
/ Phosphatidylinositol 3-Kinases - metabolism
/ Proteins
/ Proto-Oncogene Proteins c-akt - metabolism
/ RNA-Binding Proteins - genetics
/ RNA-Binding Proteins - metabolism
/ Science
/ TOR Serine-Threonine Kinases - metabolism
/ Tumors
